Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000686

Drug Information
NameAmobarbital
SynonymsVIROVYVQCGLCII-UHFFFAOYSA-; component of Dexamyl; Talamo; Eunoctal; Amytal; Dormytal; ZINC04811698; Amobarbitalum [INN-Latin]; Amital; Sumital; 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(3-methylbutyl)-; Isomyl; NSC120800; Binoctal; Amobarbital [INN:JAN]; Amobarbitone; Amospan; Oprea1_587446; 5-Ethyl-5-isopentylbarbituric acid; Amylobarbitone; 5-Ethyl-5-isopentylbarbitursaeure; Amylobarbital; CCRIS 5454; IDI1_000994; MolPort-004-285-843; amobarbital; DB01351; Isoamylethylbarbituric acid; DivK1c_000994; component of Amo-Dextrosule; Amobarbitalum; Somnal; CBDivE_006514; Amobarbitale [DCIT]; 5-Ethyl-5-isoamylmalonyl urea; KBio1_000994; 64-43-7 (hydrochloride); D00555; AMAL; UNII-GWH6IJ239E; 5-ethyl-5-(3-methylbutyl)-1,3-diazinane-2,4,6-trione; 5-Ethyl-5-(3-methylbutyl)-2,4,6(1H,3H,5H)-pyrimidinetrione; Barbamyl; Mylodorm; CID2164; LS-7196; Amybal; Dorlotyn; 5-Isoamyl-5-ethylbarbituric acid; Amobarbitale; Schiwanox; NSC 10815; NINDS_000994; HSDB 3286; Pentymal; NSC32406; DEA No. 2126; InChI=1/C11H18N2O3/c1-4-11(6-5-7(2)3)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16); NSC10815; Barbamil; 57-43-2; Isomytal (TN); Amobarbital suppository dosage form; Stadadorm; ZINC04811699; CHEMBL267894; component of Q-Caps; Isomytal; EINECS 200-330-7; Robarb; Amasust; Amylbarbitone; component of 15-90; Amobarbital (JP15/INN); 5-Ethyl-5-(3-methylbutyl)barbituric acid; Barbamyl acid; WLN: T6VMVMV FHJ F2 F2Y1&1; Sednotic; Barbituric acid, 5-ethyl-5-isopentyl-; Pentymalum; AC1L1D2C; C07536; Ethylisopentylbarbituric acid; BIDD:PXR0091; 5-Ethyl-5-isoamylbarbituric acid; CHEBI:2673; 5-ethyl-5-(3-methylbutyl)pyrimidine-2,4,6(1H,3H,5H)-trione
IndicationInsomnia
[ICD9: 307.41, 307.42, 327.0, 780.51, 780.52   ICD10: F51.0, G47.0]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C11H18N2O3/c1-4-11(6-5-7(2)3)8(14)12-10(16)13-9(11)15/h7H,4-6H
2,1-3H3,(H2,12,13,14,15,16)
InChIKeyVIROVYVQCGLCII-UHFFFAOYSA-N
Canonical SMILESCCC1(C(=O)NC(=O)NC1=O)CCC(C)C    
Therapeutic ClassHypnotics and Sedatives
CAS NumberCAS 57-43-2
FormulaC11H18N2O3
PubChem Compound IDCID 2164.
PubChem Substance IDSID 9739.
ChEBI2673;
SuperDrug ATC IDN05CA02
SuperDrug CAS ID000057432;
TargetGamma-aminobutyric acid receptor subunit alpha-1Antagonist[2][3]
Ref 1Drug information of Amobarbital, 2008 To Reference
Ref 2DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008 Jan;36(Database issue):D901-6. Epub 2007 Nov 29. To Reference
Ref 3Effect of barbiturates on polyphosphoinositide biosynthesis and protein kinase C activity in synaptosomes. Neuropharmacology. 1989 Dec;28(12):1317-23. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543